PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1993 February; 86(2): 83–86.
PMCID: PMC1293855

Balloon dilatation of the prostate--should it have a place in the urologist's armamentarium?

Abstract

Transurethral balloon dilatation of the prostate is a safe method of treating benign prostatic hyperplasia; it has been largely free of complications, and does not produce retrograde ejaculation. However doubts remain over its efficacy. We have performed balloon dilatation on 28 patients using balloons of diameter 30 mm (90F), and one year follow-up data is now available on 20 patients. Nine patients were satisfied with the outcome of treatment and reported reductions in their symptom score by a mean of 8.8 points. In addition, eight of these patients showed a reduction in their ultrasound residual volume by a mean volume of 75 ml. However urinary flow rate was only improved in four. Of the remaining 11 patients, two showed some initial improvement but then relapsed and nine derived no benefit from the procedure. We conclude that balloon dilatation may be of value in younger patients wishing to avoid or delay TURP, but is unlikely to achieve wider application.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (989K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Roos NP, Wennberg JE, Malenka DJ, Fisher ES, McPherson K, Andersen TF, Cohen MM, Ramsey E. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989 Apr 27;320(17):1120–1124. [PubMed]
  • Kirby RS, Coppinger SW, Corcoran MO, Chapple CR, Flannigan M, Milroy EJ. Prazosin in the treatment of prostatic obstruction. A placebo-controlled study. Br J Urol. 1987 Aug;60(2):136–142. [PubMed]
  • Fabricius PG, Weizert P, Dunzendorfer U, Hannaford JM, Maurath C. Efficacy of once-a-day terazosin in benign prostatic hyperplasia: a randomized, double-blind placebo-controlled clinical trial. Prostate Suppl. 1990;3:85–93. [PubMed]
  • Kirby RS, Bryan J, Eardley I, Christmas TJ, Liu S, Holmes SA, Vale JA, Shanmuganathan K, Webb JA. Finasteride in the treatment of benign prostatic hyperplasia. A urodynamic evaluation. Br J Urol. 1992 Jul;70(1):65–72. [PubMed]
  • Harrison NW, De Souza JV. Prostatic stenting for outflow obstruction. Br J Urol. 1990 Feb;65(2):192–196. [PubMed]
  • Chapple CR, Milroy EJ, Rickards D. Permanently implanted urethral stent for prostatic obstruction in the unfit patient. Preliminary report. Br J Urol. 1990 Jul;66(1):58–65. [PubMed]
  • Lindner A, Golomb J, Siegel Y, Lev A. Local hyperthermia of the prostate gland for the treatment of benign prostatic hypertrophy and urinary retention. A preliminary report. Br J Urol. 1987 Dec;60(6):567–571. [PubMed]
  • Yerushalmi A, Fishelovitz Y, Singer D, Reiner I, Arielly J, Abramovici Y, Catsenelson R, Levy E, Shani A. Localized deep microwave hyperthermia in the treatment of poor operative risk patients with benign prostatic hyperplasia. J Urol. 1985 May;133(5):873–876. [PubMed]
  • DEISTING W. Transurethral dilatation of the prostate. Urol Int. 1956;2(3):158–171. [PubMed]
  • Burhenne HJ, Chisholm RJ, Quenville NF. Prostatic hyperplasia: radiological intervention. Work in progress. Radiology. 1984 Sep;152(3):655–657. [PubMed]
  • Castaneda F, Lund G, Larson BW, Limas E, Urness M, Reddy P, Wasserman N, Hulbert J, Hunter DW, Castaneda-Zuniga WR, et al. Prostatic urethra: experimental dilation in dogs. Radiology. 1987 Jun;163(3):645–648. [PubMed]
  • Boyarsky S, Jones G, Paulson DF, Prout GR., Jr A new look at bladder neck obstruction by the food and drug administration regulators: guide lines for investigation of benign prostatic hypertrophy. Trans Am Assoc Genitourin Surg. 1976;68:29–32. [PubMed]
  • Wasserman NF, Reddy PK, Zhang G, Berg PA. Experimental treatment of benign prostatic hyperplasia with transurethral balloon dilation of the prostate: preliminary study in 73 humans. Radiology. 1990 Nov;177(2):485–494. [PubMed]
  • Daughtry JD, Rodan BA, Bean WJ. Balloon dilation of prostatic urethra. Urology. 1990 Sep;36(3):203–209. [PubMed]
  • Dowd JB, Smith JJ., 3rd Balloon dilatation of the prostate. Urol Clin North Am. 1990 Aug;17(3):671–677. [PubMed]
  • Goldenberg SL, Perez-Marrero RA, Lee LM, Emerson L. Endoscopic balloon dilation of the prostate: early experience. J Urol. 1990 Jul;144(1):83–88. [PubMed]
  • Gill KP, Machan LS, Allison DJ, Williams G. Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation. Br J Urol. 1989 Dec;64(6):618–622. [PubMed]
  • Klein LA, Lemming B. Balloon dilatation for prostatic obstruction. Long-term follow-up. Urology. 1989 Mar;33(3):198–201. [PubMed]
  • McLoughlin J, Keane PF, Jager R, Gill KP, Machann L, Williams G. Dilatation of the prostatic urethra with 35 mm balloon. Br J Urol. 1991 Feb;67(2):177–181. [PubMed]
  • Mebust WK, Holtgrewe HL, Cockett AT, Peters PC. Transurethral prostatectomy: immediate and postoperative complications. A cooperative study of 13 participating institutions evaluating 3,885 patients. J Urol. 1989 Feb;141(2):243–247. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press